Zacks Investment Research on MSN
Synopsys (SNPS) stock falls amid market uptick: What investors need to know
In the latest close session, Synopsys (SNPS) was down 1.59% at $501.39. The stock's performance was behind the S&P 500's ...
Dual-eligible individuals — those who qualify for both Medicare and Medicaid — often face complex health needs and barriers to accessing care. Read full article: VIDEO: Splendora police use grappling ...
NEW YORK, NY / ACCESS Newswire / December 3, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Synopsys, Inc. (SNPS) class action securities lawsuit A Class Action lawsuit was filed on behalf ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results